Which MRI scan best spots lung cancer spread to the brain?
NCT ID NCT02250755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 30 adults with lung cancer that had spread to the brain. Researchers compared two standard MRI sequences (T1 and T2*) to see which one better detects and tracks brain metastases after chemotherapy or targeted therapy. The goal is to improve diagnosis and monitoring without adding extra scans or contrast.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MRI with gadolinium contrast
- What this could lead to
- If successful, this could help doctors choose the best MRI sequence for diagnosing and tracking brain metastases from lung cancer, improving accuracy without extra tests.
- What could go wrong
- This is a small, completed study with only 30 participants, so results may not apply to all patients. It compares existing techniques, not a new treatment, so impact is limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER METASTATIC TO THE BRAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Salengro CHRU de Lille
Lille, 59037, France